What laboratory tests should be ordered for a patient with a rounded moon‑shaped face and recent weight gain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Workup for Moon Face and Weight Gain

Order an overnight 1-mg dexamethasone suppression test, 24-hour urinary free cortisol (2-3 collections), and late-night salivary cortisol (2-3 samples) to screen for Cushing's syndrome, as moon facies with weight gain is a highly specific clinical presentation for hypercortisolism. 1

Clinical Context

Moon face combined with weight gain—particularly when centrally distributed—represents one of the most specific physical findings for Cushing's syndrome and warrants immediate biochemical screening. 1 The combination of abnormal fat distribution affecting the face, neck, and trunk with metabolic derangements is highly specific for cortisol excess and distinguishes true Cushing's syndrome from simple obesity. 2, 3

Essential Pre-Test Step

Before ordering any biochemical tests, obtain a comprehensive medication history to exclude all sources of exogenous glucocorticoids—including oral tablets, inhaled steroids (fluticasone), topical creams, intra-articular/epidural injections, and over-the-counter supplements. 4, 5 Failure to exclude iatrogenic Cushing's syndrome leads to unnecessary testing without clinical benefit. 1, 4

First-Line Screening Tests (Order All Three)

1. Overnight 1-mg Dexamethasone Suppression Test

  • Protocol: Give 1 mg dexamethasone orally between 11 PM-midnight; measure serum cortisol at 8 AM the next morning. 1, 5
  • Interpretation: Cortisol ≥1.8 μg/dL (≥50 nmol/L) indicates abnormal suppression; cortisol >5 μg/dL (138 nmol/L) indicates overt Cushing's syndrome. 4, 5
  • Enhanced accuracy: Consider measuring dexamethasone levels concomitantly with cortisol to confirm adequate drug absorption and exclude false-positive results from rapid metabolism. 1, 4, 5
  • Advantages: Does not depend on fixed bedtime collection, making it suitable for patients with irregular sleep schedules. 5
  • Pitfalls: Oral contraceptives/estrogen therapy can cause false-positive results by elevating cortisol-binding globulin; CYP3A4 inducers (phenytoin, rifampin, carbamazepine) accelerate dexamethasone metabolism causing false-positives. 4, 5

2. 24-Hour Urinary Free Cortisol (UFC)

  • Protocol: Collect 2-3 separate 24-hour urine samples on different days. 1, 4, 5
  • Interpretation: Values >100 μg/24 hours (1.6 μmol/24 hours) on multiple collections are diagnostic in symptomatic patients. 4, 5
  • Critical requirement: Measure urine volume and total creatinine excretion to verify collection completeness—incomplete collections are the most common cause of false results. 4
  • Rationale for multiple collections: UFC can vary by up to 50% between collections due to biological variability. 4, 5
  • Pitfalls: Renal impairment or polyuria invalidates results; copper contamination of collection containers causes spurious results. 4

3. Late-Night Salivary Cortisol (LNSC)

  • Protocol: Collect saliva samples at the patient's usual bedtime (11 PM-midnight) on 2-3 consecutive nights. 4, 5
  • Interpretation: Values >3.6 nmol/L (>0.1 μg/dL) indicate loss of normal circadian rhythm. 4, 5
  • Diagnostic performance: Sensitivity 92-100%, specificity 93-100%—the highest specificity among all first-line screening tests. 5
  • Advantages: Easiest for patient compliance; multiple short-duration collections are simpler than 24-hour urine. 1, 5
  • Absolute contraindication: Do NOT perform in night-shift workers or anyone with disrupted sleep-wake cycles, as the test relies on normal nocturnal cortisol nadir. 5
  • Pitfalls: Topical hydrocortisone preparations contaminate samples; blood contamination from dental work or oral trauma within 1-2 hours falsely elevates results. 4

Interpretation Algorithm

If ≥2 Screening Tests Are Abnormal

  1. Measure 9 AM plasma ACTH to determine etiology. 1, 5, 2
    • Low/undetectable ACTH (<5 ng/L or <1.1 pmol/L): Indicates ACTH-independent (adrenal) Cushing's syndrome → proceed to adrenal CT/MRI. 1, 5, 2
    • Normal/elevated ACTH (>5 ng/L or >1.1 pmol/L): Indicates ACTH-dependent (pituitary or ectopic) Cushing's syndrome → proceed to pituitary MRI. 1, 5, 2

If Only 1 Test Is Abnormal

  • Repeat 1-2 screening tests to confirm hypercortisolism before proceeding to ACTH measurement. 5
  • Consider cyclic Cushing's syndrome if results remain inconsistent—this condition produces weeks to months of normal cortisol interspersed with excess. 4, 5

If All Tests Are Normal

  • Cushing's syndrome is unlikely if clinical suspicion is low to moderate. 5
  • If clinical suspicion remains high despite normal tests, refer to endocrinology for extended monitoring with multiple sequential LNSC measurements over 3-6 months. 4, 5

Additional Considerations

Pseudo-Cushing's States (False-Positive Screening)

The following conditions can mimic Cushing's syndrome biochemically and must be considered when interpreting abnormal results: 4, 5

  • Severe obesity
  • Major depression or anxiety disorders
  • Chronic alcoholism
  • Uncontrolled diabetes
  • Polycystic ovary syndrome
  • Pregnancy

Management: Treat the underlying condition and repeat biochemical testing after 3-6 months. 5

Paraneoplastic Cushing's Syndrome

In patients with known or suspected lung cancer (especially small cell lung cancer or bronchial carcinoid), moon facies with weight gain should raise suspicion for ectopic ACTH production. 1 Additional features include: 1

  • Skin hyperpigmentation (more prominent with ectopic ACTH)
  • Hypokalemia with metabolic alkalosis
  • Rapid onset of symptoms
  • Weight loss (occurs in ~10% of SCLC-associated cases)

Thyroid Function Testing

Although less likely given the specific presentation, consider adding TSH and free T4 to exclude hypothyroidism, which can also present with weight gain and facial puffiness (though not true moon facies). 1 This is particularly relevant if the patient has additional features such as cold intolerance, constipation, or delayed ankle reflexes. 1

Critical Pitfalls to Avoid

  • Never proceed to ACTH measurement or imaging without first confirming hypercortisolism with abnormal screening tests. 5
  • Never use bilateral inferior petrosal sinus sampling to diagnose hypercortisolism—it is reserved solely for localizing ACTH source after biochemical confirmation. 5
  • Always verify that exogenous glucocorticoids have been excluded before interpreting any cortisol test. 4, 5
  • Do not rely on a single abnormal screening test—repeat testing is essential to minimize false-positive diagnoses. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Adrenal Cushing's Syndrome Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Toward a Diagnostic Score in Cushing's Syndrome.

Frontiers in endocrinology, 2019

Guideline

Cortisol Levels and Diagnostic Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosing Cushing's Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the next step in managing a patient with hypercortisolism and an adrenocorticotropic hormone (ACTH) level of 16 that is not suppressed?
What are the diagnostic steps and treatment options for Cushing's syndrome?
What is the next step in management for a 30-year-old woman with suspected Cushing's syndrome (CS), presenting with muscle weakness, weight gain, facial plethora, supraclavicular fat pads, truncal obesity, and purple striae, as well as hypertension (high blood pressure)?
What is the diagnostic and treatment approach for a patient suspected of having Cushing's syndrome?
What is the recommended evaluation and treatment approach for a patient suspected of having Cushing's syndrome?
Can duloxetine be prescribed to a patient who is taking apixaban (Eliquis)?
What is the significance of an NT‑proBNP level of 1,343 pg/mL in an adult over 50 and how should it be evaluated and managed?
In a 32‑year‑old gravida 3 woman with premature rupture of membranes for 4 hours, no uterine contractions, hemodynamically stable and receiving intravenous antibiotics, which neonatal complication is most likely reduced?
What is the recommended dosing regimen and monitoring for the combination of mitomycin C (mitomycin) and epirubicin (epirubicin) in a patient with a solid tumor, including adjustments for renal or hepatic impairment?
In a 65‑year‑old man with end‑stage renal disease on peritoneal dialysis, long‑standing diabetes mellitus and a prior right great‑toe amputation, what are the likely causes of new right foot numbness and how should it be evaluated and managed?
In a 32‑year‑old gravida 3 woman with premature rupture of membranes for 4 hours, no uterine contractions, hemodynamically stable and receiving intravenous antibiotics, which neonatal complication is most likely reduced by the antibiotics?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.